• New Drugs Approved
    • 2024 Approvals
    • 2023 Approvals
  • Health and Medical Research News
    • Arthritis
    • Bronchitis
    • Cancer
    • Diabetes
    • Eye
    • Heart Conditions
    • Vaccines and Infections
    • Mental Health
    • Neurology
    • Pain Conditions
    • Skin Conditions
    • Stomach & Intestine
OJJAARA: A New Treatment for Myelofibrosis Approved by the FDA on September 15, 2023

OJJAARA: A New Treatment for Myelofibrosis Approved by the FDA on September 15, 2023

by B Jamerson | Jul 22, 2024 | 2023 Approvals, Drug approvals

What is OJJAARA prescribed for?  OJJAARA is prescribed to treat intermediate or high-risk myelofibrosis in adults with anemia.  What is the name of the drug and what does it do? OJJAARA, pronounced oh-JAR-uh, (generic name: momelotinib) is a medication...
APHEXDA: A New Frontier in Multiple Myeloma Treatment Approved by the FDA on September 8, 2023

APHEXDA: A New Frontier in Multiple Myeloma Treatment Approved by the FDA on September 8, 2023

by B Jamerson | Jul 22, 2024 | 2023 Approvals, Drug approvals

What is APHEXDA prescribed for?  APHEXDA is used in combination with filgrastim (G-CSF) to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with multiple myeloma. What is the name of...
FDA Approves VEOPOZ on August 18th 2023: A New Treatment for CHAPLE Disease

FDA Approves VEOPOZ on August 18th 2023: A New Treatment for CHAPLE Disease

by B Jamerson | Jul 22, 2024 | 2023 Approvals, Drug approvals

What is VEOPOZ prescribed for?   VEOPOZ is prescribed to treat patients 1 year old and older with CD55-deficient protein-losing enteropathy (PLE), also known as CHAPLE disease. What is the name of the drug and what does it do? The drug, VEOPOZ, pronounced...
FDA Approves JESDUVROQ for Anemia in Chronic Kidney Disease Patients on Dialysis on February 1, 2023

FDA Approves JESDUVROQ for Anemia in Chronic Kidney Disease Patients on Dialysis on February 1, 2023

by B Jamerson | Jul 22, 2024 | 2023 Approvals, Drug approvals, New Drugs Approved

What is JESDUVROQ prescribed for?   To treat anemia caused by chronic kidney disease for adults on dialysis for at least four months.  What is the name of the drug and what does it do?  JESDUVROQ  (generic name: daprodustat), pronounced...
FDA Approves ORSERDU for Advanced Breast Cancer on January 27, 2023

FDA Approves ORSERDU for Advanced Breast Cancer on January 27, 2023

by B Jamerson | Jul 22, 2024 | 2023 Approvals, Cancer, Drug approvals, New Drugs Approved

What is ORSERDU prescribed for?   For treatment of postmenopausal women or adult men, with ERpositive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy What is the name...
Page 18 of 22« First«...10...1617181920...»Last »

Latest Posts

  • Research Progress for Chronic Bronchitis: Sulforaphane Strengthens Lung Defenses
  • Do All Men with Prostate Cancer Get the Same Treatment? A Look at Racial and Ethnic Gaps
  • New Light on Osteoarthritis: Innovative Imaging Techniques Unveil Early Joint Damage
  • New Combination Therapy Shows Promise for Advanced Urinary Tract Cancer
  • New Discovery Could Lead to Better Treatments for Rheumatoid Arthritis

ScienceMyHealth is a product of iSimcha.

Navigate

HomePage

Blog

 

Company

About Us

Contact Us

© 2025 iSimcha

Privacy Policy

Terms of Service